Published in JAMA on September 06, 2006
Building a diverse physician workforce. JAMA (2006) 1.83
Characteristics of medical school matriculants who participated in postbaccalaureate premedical programs. Acad Med (2011) 1.53
Undergraduate cancer training program for underrepresented students: findings from a minority institution/cancer center partnership. J Cancer Educ (2010) 1.02
Addressing the primary care physician shortage in an evolving medical workforce. Int Arch Med (2009) 0.89
An integrative review and evidence-based conceptual model of the essential components of pre-service education. Hum Resour Health (2013) 0.84
An Educational Program for Underserved Middle School Students to Encourage Pursuit of Pharmacy and Other Health Science Careers. Am J Pharm Educ (2014) 0.84
Facilitating admissions of diverse students: A six-point, evidence-informed framework for pipeline and program development. Perspect Med Educ (2017) 0.81
Community health center access to resources for their patients with diabetes. J Immigr Minor Health (2014) 0.76
Funding crisis in Title VII diversity programs. Am J Public Health (2007) 0.76
Postbaccalaureate premedical programs to promote physician-workforce diversity. J Best Pract Health Prof Divers (2015) 0.75
A National Long-term Outcomes Evaluation of U.S. Premedical Postbaccalaureate Programs Designed to Promote Health care Access and Workforce Diversity. J Health Care Poor Underserved (2015) 0.75
Increasing medical school matriculation for minority students. JAMA (2007) 0.75
Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis. J Clin Oncol (2013) 3.76
Feasibility and benefits of second-line chemotherapy in advanced biliary tract cancer: a large retrospective study. Eur J Cancer (2012) 2.54
Combining gemcitabine and capecitabine in patients with advanced biliary cancer: a phase II trial. J Clin Oncol (2005) 2.52
Optimizing adoptive polyclonal T cell immunotherapy of lymphomas, using a chimeric T cell receptor possessing CD28 and CD137 costimulatory domains. Hum Gene Ther (2007) 2.23
SAVE (Super-dose anti-VEGF) trial: 2.0 mg ranibizumab for recalcitrant neovascular age-related macular degeneration: 1-year results. Ophthalmic Surg Lasers Imaging Retina (2013) 1.60
Combining Smoothened Agonist (SAG) and NEL-like protein-1 (NELL-1) Enhances Bone Healing. Plast Reconstr Surg (2017) 1.40
Natural course of distant metastases following radiotherapy or chemoradiotherapy in HPV-related oropharyngeal cancer. Oral Oncol (2012) 1.38
Determination of chemical agent optical clearing potential using in vitro human skin. Lasers Surg Med (2005) 1.24
Phase 1 trial of the oral AKT inhibitor MK-2206 plus carboplatin/paclitaxel, docetaxel, or erlotinib in patients with advanced solid tumors. J Hematol Oncol (2014) 1.20
Host factors that affect Ty3 retrotransposition in Saccharomyces cerevisiae. Genetics (2004) 1.19
Outcomes of HPV-related oropharyngeal cancer patients treated by radiotherapy alone using altered fractionation. Radiother Oncol (2012) 1.12
Phase 2 trial of preoperative irinotecan plus cisplatin and conformal radiotherapy, followed by surgery for esophageal cancer. Cancer (2010) 1.08
Effects of combined inhibition of MEK and mTOR on downstream signaling and tumor growth in pancreatic cancer xenograft models. Cancer Biol Ther (2009) 1.06
Super-dose anti-VEGF (SAVE) trial: 2.0 mg intravitreal ranibizumab for recalcitrant neovascular macular degeneration-primary end point. Ophthalmology (2012) 1.05
Multiple dysregulated pathways in nasopharyngeal carcinoma revealed by gene expression profiling. Int J Cancer (2006) 1.04
A dataset of human liver proteins identified by protein profiling via isotope-coded affinity tag (ICAT) and tandem mass spectrometry. Mol Cell Proteomics (2004) 1.03
Foreign versus domestic education of physicians for the United States: a case study of physicians of South Asian ethnicity in California. J Health Care Poor Underserved (2007) 1.02
Calcium phosphate-DNA nanoparticle gene delivery from alginate hydrogels induces in vivo osteogenesis. J Biomed Mater Res A (2010) 0.98
Cascade of reduced speed and accuracy after errors in enzyme-free copying of nucleic acid sequences. J Am Chem Soc (2012) 0.97
Induction of apoptosis in IL-3-dependent hematopoietic cell lines by guanine nucleotide depletion. Blood (2003) 0.95
Hypotony after 25-gauge vitrectomy using oblique versus direct cannula insertions in fluid-filled eyes. Retina (2008) 0.93
A Phase I trial of prolonged administration of lovastatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck or of the cervix. Eur J Cancer (2005) 0.93
A phase II trial of second-line axitinib following prior antiangiogenic therapy in advanced hepatocellular carcinoma. Cancer (2015) 0.92
Ancient eudicot hexaploidy meets ancestral eurosid gene order. BMC Genomics (2013) 0.92
A phase I/II study of the Src inhibitor saracatinib (AZD0530) in combination with gemcitabine in advanced pancreatic cancer. Invest New Drugs (2010) 0.92
How leaky is the health career pipeline? Minority student achievement in college gateway courses. Acad Med (2009) 0.91
Decreased dendritic spine density and abnormal spine morphology in Fyn knockout mice. Brain Res (2011) 0.91
Host factor transcriptional regulation contributes to preferential expression of HIV type 1 in IL-4-producing CD4 T cells. J Immunol (2012) 0.88
A multicenter, randomized, open-label study to assess the steady-state pharmacokinetics of bevacizumab given with either XELOX or FOLFOX-4 in patients with metastatic colorectal cancer. Cancer Chemother Pharmacol (2011) 0.88
Change in spinal alignment after total hip arthroplasty. Orthop Surg (2013) 0.85
Sequence dependence of MEK inhibitor AZD6244 combined with gemcitabine for the treatment of biliary cancer. Clin Cancer Res (2012) 0.83
A comparison of the Functional Independence Measure and Morse Fall Scale as tools to assess risk of fall on an inpatient rehabilitation. Rehabil Nurs (2013) 0.83
Investigation of metamemory dysfunctions in first-episode schizophrenia. Schizophr Res (2005) 0.83
Comparison of spectral-domain and time-domain optical coherence tomography in the detection of neovascular age-related macular degeneration activity. Retina (2014) 0.83
Recurrent glomerulonephritis under rapid discontinuation of steroids. Transplantation (2011) 0.82
Suicidality among high school students in Hong Kong, SAR. Suicide Life Threat Behav (2004) 0.82
Each individual isoform of the dopamine D2 receptor protects from lactotroph hyperplasia. Mol Endocrinol (2013) 0.80
Xenopus oocyte meiosis lacks spindle assembly checkpoint control. J Cell Biol (2013) 0.80
A phase II study of capecitabine, irinotecan, and bevacizumab in patients with previously untreated metastatic colorectal cancer. Cancer Chemother Pharmacol (2012) 0.80
Efficacy of valproate versus lithium in mania or mixed mania: a randomized, open 12-week trial. Int Clin Psychopharmacol (2010) 0.78
FDA perspective on clinical trial design for cardiovascular devices. Ann Thorac Surg (2006) 0.77
MRI predicts remission at 1 year in first-episode schizophrenia in females with larger striato-thalamic volumes. Neuropsychobiology (2014) 0.77
Cytomegalovirus retinitis after treatment with intravitreal triamcinolone acetonide in an immunocompetent patient. Retin Cases Brief Rep (2007) 0.75
Response to letter 'outcome of second-line chemotherapy for biliary tract cancer'. Eur J Cancer (2012) 0.75
Bilateral Herpetic Keratitis After Bilateral Intravitreal Bevacizumab for Exudative Macular Degeneration. Cornea (2017) 0.75
Agnathia-otocephaly. J La State Med Soc (2009) 0.75
ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION: Role of Prophylactic Topical Ophthalmic Antibiotics. Retina (2016) 0.75
Predictors of students' success in community college nursing programs. J Nurs Educ (2012) 0.75
Is pelvic obliquity related to degenerative scoliosis? Orthop Surg (2013) 0.75
THE ASSOCIATION OF EPIRETINAL MEMBRANE WITH MACULAR HOLE FORMATION AFTER RHEGMATOGENOUS RETINAL DETACHMENT REPAIR. Retina (2017) 0.75
Reducing acute kidney injury due to vancomycin in trauma patients. J Trauma Acute Care Surg (2016) 0.75
US FDA perspective on regulatory issues affecting circulatory assist devices. Expert Rev Med Devices (2006) 0.75
Looking for a flu killer. Interview by Anna Kuchment. Sci Am (2013) 0.75
A US Food and Drug Administration perspective on cardiac resynchronization and ventricular assist device trials. Congest Heart Fail (2005) 0.75
Use of cox-2 inhibitors in patients with retinal venous occlusive disease. Retina (2008) 0.75
The Kernel of Maximum Agreement Subtrees. IEEE/ACM Trans Comput Biol Bioinform (2012) 0.75